Remedee Labs
Remedee is the next generation pain relief offering a new and individualized therapy to every patient.
Total raised
€23M
€22,520,000
Funding rounds
2
Investors
6
distinct backers
Active since
2019-09
latest 2022-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 14y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-06 | Series A | €12M | BPI,Generali France,Habert Dassault Finance,HCVC,Private Investors | View deal → |
| 2019-10-01 | Series A | €10M | Hardware Club | View deal → |
Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software